Preserving Spinal Motion, Preserving Options
This article was originally published in Start Up
Executive Summary
Dynamic stabilization may sound like an oxymoron, but the concept is driving compound annual growth of more than 50% over the next decade in a new segment of the spine industry. The US market for spinal motion preserving and nonfusion products was worth approximately $186 million in 2004, and is projected to reach more than $1.5 billion in the year 2009, according to "US Markets for Spinal Motion Preserving Devices," a report just published by Windhover/Medtech Insight.
You may also be interested in...
Paradigm Spine LLC
Paradigm Spine is building a pipeline of dynamic stabilization devices based on two core technology platforms: coflex interspinous spacers for stenosis and Orthobiom implants for adolescent idiopathic scoliosis. The three-year-old company is rolling out products at a rapid pace: it will have five devices on ex-US markets by the middle of this year.
Business & Technology Briefs (01/2007)
A short summary of recent market and product developments in Interventional Cardiology, Spine Surgery, and Aesthetics, including: DES Safety Panel Weighs the Evidence; Percutaneous Lubar Fusion, and New Dermal Fillers.
Dynamic Stabilization Rocks Spine
In the US acceptance of dynamic stabilization devices (DYNs) has been strong owing to the compelling advantages of DYNs over artificial discs, including that they can be implanted from a posterior route, do not violate the disc space and the procedure is reversible. Rather being an alternative to fusion, artificial discs will likely compete with DYNs.